NCT04666584

Brief Summary

The aim of the study is to investigate if lesion preparation with a ScoreFlex balloon compared to a standard non-compliant balloon improve vascular healing and minimize lumen reduction after implantation of a Magmaris bioresorbable scaffold.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
82

participants targeted

Target at P25-P50 for not_applicable coronary-artery-disease

Timeline
Completed

Started Dec 2020

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 14, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

December 14, 2020

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2024

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

3.2 years

First QC Date

November 27, 2020

Last Update Submit

September 12, 2023

Conditions

Keywords

bioresorbable scaffoldsoptical coherence tomographyintravascular ultrasoundmodified balloons

Outcome Measures

Primary Outcomes (1)

  • Minimal Lumen Area

    Minimal Lumen Area

    6 months after index percutaneous coronary intervention

Secondary Outcomes (4)

  • Change in remodeling Index

    6 months and 12 months after index percutaneous coronary intervention

  • Change in Minimal Lumen Area

    6 months and 12 months after index percutaneous coronary intervention

  • Percentage of incomplete scaffold apposition

    6 months and 12 months after index percutaneous coronary intervention

  • Percentage of uncovered struts

    6 months and 12 months after index percutaneous coronary intervention

Study Arms (2)

ScoreFlex balloon

ACTIVE COMPARATOR

Pre-dilatation with a ScoreFlex balloon before implantation with a Magmaris bioresorbable scaffold

Device: ScoreFlex balloon

Standard non-compliant balloon

ACTIVE COMPARATOR

Pre-dilatation with a non-compliant balloon before implantation with a Magmaris bioresorbable scaffold

Device: Device: standard non-compliant balloon

Interventions

Pre-dilatation with a ScoreFlex balloon

ScoreFlex balloon

Pre-dilatation with a standard non-compliant balloon

Standard non-compliant balloon

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with stable angina pectoris and non-ST elevation myocardial infarction referred for invasive coronary angiography and percutaneous coronary intervention at Department of Cardiology, Odense University Hospital (Odense, Denmark)

You may not qualify if:

  • participation in other randomized clinical trials
  • life expectancy \< 1 year
  • allergy to aspirin, clopidogrel, ticagrelor or prasugrel
  • eGFR \< 30 mL/min
  • tortuous and angiographically estimated extremely calcified lesions
  • ostial, left main and bifurcation lesions
  • lesions in a reference vessel diameter \< 2.0 mm
  • hemodynamic instability
  • scheduled for coronary artery bypass grafting

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital

Odense, 5000, Denmark

Location

Related Publications (2)

  • Hansen KN, Maehara A, Troan J, Noori M, Hougaard M, Ellert-Gregersen J, Veien KT, Junker A, Hansen HS, Lassen JF, Jensen LO. Mechanistic insights into lumen reduction after implantation of a drug-eluting bioresorbable metallic scaffold assessed with serial intracoronary imaging: from the OPTIMIS trial. Coron Artery Dis. 2026 Mar 1;37(2):84-94. doi: 10.1097/MCA.0000000000001561. Epub 2025 Aug 20.

  • Hansen KN, Troan J, Maehara A, Noori M, Hougaard M, Ellert-Gregersen J, Veien KT, Junker A, Hansen HS, Lassen JF, Jensen LO. Optimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial. Circ Cardiovasc Interv. 2025 Jan;18(1):e014665. doi: 10.1161/CIRCINTERVENTIONS.124.014665. Epub 2025 Jan 21.

MeSH Terms

Conditions

Coronary Artery DiseaseAngina, StableCoronary StenosisMyocardial InfarctionCardiovascular DiseasesMyocardial IschemiaCoronary DiseaseHeart DiseasesArterial Occlusive Diseases

Condition Hierarchy (Ancestors)

ArteriosclerosisVascular DiseasesAngina PectorisChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsInfarctionIschemiaPathologic ProcessesNecrosis

Study Officials

  • Lisette O. Jensen, MD PhD Prof

    Odense University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Offline data analysis will be performed without knowing the allocated intervention group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Eligible patients randomized to predilatation with ScoreFlex balloon or a standard non-compliant balloon before percutaneous coronary intervention with implantation of a Magmaris bioresorbable scaffold.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 27, 2020

First Posted

December 14, 2020

Study Start

December 14, 2020

Primary Completion

March 8, 2024

Study Completion

December 31, 2024

Last Updated

September 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations